BACKGROUND: Patient-level risk factors for delayed graft function (DGF) have been well described. However, the Organ Procurement and Transplantation Network definition of DGF is based on dialysis in the first week, which is subject to center-level practice patterns. It remains unclear if there are center-level differences in DGF and if measurable center characteristics can explain these differences. METHODS: Using the 2003 to 2012 Scientific Registry of Transplant Recipients data, we developed a hierarchical (multilevel) model to determine the association between center characteristics and DGF incidence after adjusting for known patient risk factors and to quantify residual variability across centers after adjustment for these factors. RESULTS: Of 82,143 deceased donor kidney transplant recipients, 27.0% developed DGF, with a range across centers of 3.2% to 63.3%. A center's proportion of preemptive transplants (odds ratio [OR], 0.83; per 5% increment; 95% confidence interval [95% CI], 0.74-;0.93; P = 0.001) and kidneys with longer than 30 hr of cold ischemia time (CIT) (OR, 0.95; per 5% increment; 95% CI, 0.92-;0.98; P = 0.001) were associated with less DGF. A center's proportion of donation after cardiac death donors (OR, 1.12; per 5% increment; 95% CI, 1.03-;1.17; P < 0.001) and imported kidneys (OR, 1.06; per 5% increment; 95% CI, 1.03-;1.10; P < 0.001) were associated with more DGF. After patient-level and center-level adjustments, only 41.8% of centers had DGF incidences consistent with the national median and 28.2% had incidences above the national median. CONCLUSION: Significant heterogeneity in DGF incidences across centers, even after adjusting for patient-level and center-level characteristics, calls into question the generalizability and validity of the current DGF definition. Enhanced understanding of center-level variability and improving the definition of DGF accordingly may improve DGF's utility in clinical care and as a surrogate endpoint in clinical trials.
BACKGROUND:Patient-level risk factors for delayed graft function (DGF) have been well described. However, the Organ Procurement and Transplantation Network definition of DGF is based on dialysis in the first week, which is subject to center-level practice patterns. It remains unclear if there are center-level differences in DGF and if measurable center characteristics can explain these differences. METHODS: Using the 2003 to 2012 Scientific Registry of Transplant Recipients data, we developed a hierarchical (multilevel) model to determine the association between center characteristics and DGF incidence after adjusting for known patient risk factors and to quantify residual variability across centers after adjustment for these factors. RESULTS: Of 82,143 deceased donor kidney transplant recipients, 27.0% developed DGF, with a range across centers of 3.2% to 63.3%. A center's proportion of preemptive transplants (odds ratio [OR], 0.83; per 5% increment; 95% confidence interval [95% CI], 0.74-;0.93; P = 0.001) and kidneys with longer than 30 hr of cold ischemia time (CIT) (OR, 0.95; per 5% increment; 95% CI, 0.92-;0.98; P = 0.001) were associated with less DGF. A center's proportion of donation after cardiac death donors (OR, 1.12; per 5% increment; 95% CI, 1.03-;1.17; P < 0.001) and imported kidneys (OR, 1.06; per 5% increment; 95% CI, 1.03-;1.10; P < 0.001) were associated with more DGF. After patient-level and center-level adjustments, only 41.8% of centers had DGF incidences consistent with the national median and 28.2% had incidences above the national median. CONCLUSION: Significant heterogeneity in DGF incidences across centers, even after adjusting for patient-level and center-level characteristics, calls into question the generalizability and validity of the current DGF definition. Enhanced understanding of center-level variability and improving the definition of DGF accordingly may improve DGF's utility in clinical care and as a surrogate endpoint in clinical trials.
Authors: I J Dawidson; Z F Sandor; L Coorpender; B Palmer; P Peters; C Lu; A Sagalowsky; R Risser; C Willms Journal: Transplantation Date: 1992-04 Impact factor: 4.939
Authors: Kelly D Smith; Lucile E Wrenshall; Roberto F Nicosia; Raimund Pichler; Christopher L Marsh; Charles E Alpers; Nayak Polissar; Connie L Davis Journal: J Am Soc Nephrol Date: 2003-04 Impact factor: 10.121
Authors: David Shaffer; Anthony Langone; William A Nylander; Simin Goral; A Tarik Kizilisik; J Harold Helderman Journal: Clin Transplant Date: 2003 Impact factor: 2.863
Authors: Thomas A Gonwa; Martin L Mai; Larry B Melton Douglas Smith; Marlon F Levy; Robert M Goldstein; Goran B Klintmalm Journal: Clin Transplant Date: 2002-04 Impact factor: 2.863
Authors: C Troppmann; K J Gillingham; E Benedetti; P S Almond; R W Gruessner; J S Najarian; A J Matas Journal: Transplantation Date: 1995-04-15 Impact factor: 4.939
Authors: William D Irish; David A McCollum; Raymond J Tesi; Art B Owen; Daniel C Brennan; Jane E Bailly; Mark A Schnitzler Journal: J Am Soc Nephrol Date: 2003-11 Impact factor: 10.121
Authors: Ryan A McTaggart; Danielle Gottlieb; Jessica Brooks; Peter Bacchetti; John P Roberts; Stephen Tomlanovich; Sandy Feng Journal: Am J Transplant Date: 2003-04 Impact factor: 8.086
Authors: Giovanni Stallone; Salvatore Di Paolo; Antonio Schena; Barbara Infante; Michele Battaglia; Pasquale Ditonno; Loreto Gesualdo; Giuseppe Grandaliano; Francesco Paolo Schena Journal: J Am Soc Nephrol Date: 2004-01 Impact factor: 10.121
Authors: Michal A Mankowski; Martin Kosztowski; Subramanian Raghavan; Jacqueline M Garonzik-Wang; David Axelrod; Dorry L Segev; Sommer E Gentry Journal: Am J Transplant Date: 2019-05-28 Impact factor: 8.086
Authors: Allan B Massie; Xun Luo; Bonnie E Lonze; Niraj M Desai; Adam W Bingaman; Matthew Cooper; Dorry L Segev Journal: J Am Soc Nephrol Date: 2015-12-17 Impact factor: 10.121
Authors: Vikas R Dharnidharka; Abhijit S Naik; David A Axelrod; Mark A Schnitzler; Zidong Zhang; Sunjae Bae; Dorry L Segev; Daniel C Brennan; Tarek Alhamad; Rosemary Ouseph; Ngan N Lam; Mustafa Nazzal; Henry Randall; Bertram L Kasiske; Mara McAdams-Demarco; Krista L Lentine Journal: Transpl Int Date: 2017-11-02 Impact factor: 3.782
Authors: Michael G Collins; Magid A Fahim; Elaine M Pascoe; Kathryn B Dansie; Carmel M Hawley; Philip A Clayton; Kirsten Howard; David W Johnson; Colin J McArthur; Rachael C McConnochie; Peter F Mount; Donna Reidlinger; Laura Robison; Julie Varghese; Liza A Vergara; Laurence Weinberg; Steven J Chadban Journal: Trials Date: 2020-05-25 Impact factor: 2.279
Authors: Brian J Boyarsky; William A Werbel; Christine M Durand; Robin K Avery; Kyle R Jackson; Amber B Kernodle; Jon Snyder; Ryutaro Hirose; Indraneel M Massie; Jacqueline M Garonzik-Wang; Dorry L Segev; Allan B Massie Journal: Am J Transplant Date: 2020-08-05 Impact factor: 9.369
Authors: Connie J Wang; Ahmad Tuffaha; Milind A Phadnis; Jonathan D Mahnken; James B Wetmore Journal: Ann Transplant Date: 2018-04-03 Impact factor: 1.530
Authors: Ali I Gardezi; Brenda Muth; Adil Ghaffar; Fahad Aziz; Neetika Garg; Maha Mohamed; David Foley; Dixon Kaufman; Arjang Djamali; Didier Mandelbrot; Sandesh Parajuli Journal: Kidney Int Rep Date: 2021-04-17